Screen · Berkshire Criteria

Buffett Quality Screen

Buffett's "wonderful business" criteria, quantified into six dimensions: earnings record (20), ROE quality (25 — Fortune's double standard), low leverage (15), pricing power (15), business stability (15) and capital efficiency (10), for a 0–100 total. The entry gate is the first of Berkshire's acquisition criteria — at least $50M average pre-tax earnings over the last three fiscal years (banks and insurers excluded, as leverage is their business model; investment trusts and closed-end funds excluded, as they are portfolios rather than operating companies). Recomputed periodically from each company's last ten fiscal years; cross-listings merged by canonical ticker. Hover the score for the six-dimension breakdown; companies we cover link to their report. Filtered by market "Hong Kong", market cap "Large $10–200B", Has report: 7 match(clear filters).

# Ticker Mkt Cap Score 10Y ROE Profit Streak Net Debt/Eq Gross Margin Report FY
1 Pop Mart International Group Ltd 9992 · HK $27B
68/100 Strong
26.0%low 2.0% 9 yr Net cash 61% Pop Mart: A Deep Long-Term Value StudyMay 19, 2026 · Watch FY2025
2 Chow Tai Fook Jewellery Group Ltd 1929 · HK $16B
68/100 Strong
18.2%low 9.6% 10 yr+ 0.7× 27% Chow Tai Fook Jewellery Group: A Scale Leader in Transition, Priced Around Fair ValueJun 25, 2026 · Hold FY2026
3 Lenovo Group 0992 · HK $38B
67/100 Strong
21.6%low -3.0% 8 yr 0.0× 16% Lenovo Group (0992.HK) Zen Horizon Framework Deep-Dive ResearchJun 9, 2026 · Watch FY2026
4 WuXi AppTec Co Ltd H 2359 · HK $61B
62/100 Medium
15.9%low 9.1% 10 yr+ Net cash 40% WuXi AppTec Zen Horizon Framework Deep Dive: A Fine Business, a Fair Price, and an Unresolved Geopolitical CatchJun 5, 2026 · Watch FY2025
5 Xiaomi Corp 1810 · HK $95B
56/100 Medium
12.8%low 1.7% 8 yr Net cash 16% Xiaomi Group Long-Term Owner-Oriented ResearchMay 17, 2026 · Watch FY2025
6 WuXi Biologics 2269 · HK $20B
56/100 Medium
13.2%low 6.3% 10 yr+ Net cash 43% WuXi Biologics Deep Dive: A Biologics CRDMO Where Manufacturing Delivery Runs Ahead While Valuation Is Held Back by a Geopolitical DiscountJun 12, 2026 · Hold FY2025
7 Kuaishou Technology 1024 · HK $24B
32/100 Poor
-108.0%low -585.3% 3 yr Net cash 43% Kuaishou Technology: A Deep DiveJun 14, 2026 · Cautious Buy FY2025

Data and methodology: the six dimensions quantify Berkshire's published acquisition criteria and Buffett's shareholder letters (1981/1987/1991/2007 among others). Qualitative tests in the originals (e.g. "simple, understandable business", "management in place") are out of scope, and price ("available at a fair price") is covered by each report's valuation range instead. Financials come from company annual reports (via EODHD); ratios are computed in reporting currency, the USD gate via static FX. "‡" marks companies whose equity is persistently negative or tiny (ROE falls back to ROCE); "†" marks missing gross profit (operating margin used). Investment trusts and closed-end funds are excluded on two tests — name and financial shape (operating margins beyond what an operating company can achieve); REITs and operating asset managers are unaffected. This is a quantitative first pass, not investment advice. When citing this data, please credit Zen Horizon (zh.app). See our methodology for the scoring process.